Erik Serrao
- Molecular Biology top 10%
- Virology top 0.5%
- Infectious Diseases top 2%
- Epidemiology top 10%
- Immunology top 10%
- Co-authors
- Alan EngelmanNouri NeamatiPeter CherepanovWeifeng WangSrinivas OddeKavya RamkumarGregory A. SowdHao Wang
- Topics
- HIV Research and Treatment (26 papers)HIV/AIDS drug development and treatment (17 papers)CRISPR and Genetic Engineering (8 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Erik Serrao
30 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Molecular Biology 995
- Virology 906
- Infectious Diseases 674
- Epidemiology 257
- Immunology 227
Countries citing papers authored by Erik Serrao
This map shows the geographic impact of Erik Serrao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Serrao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Serrao more than expected).
Fields of papers citing papers by Erik Serrao
This network shows the impact of papers produced by Erik Serrao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Serrao. The network helps show where Erik Serrao may publish in the future.
Co-authorship network of co-authors of Erik Serrao
This figure shows the co-authorship network connecting the top 25 collaborators of Erik Serrao. A scholar is included among the top collaborators of Erik Serrao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Serrao. Erik Serrao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | Haematopoietic stem and progenitor cells from human pluripotent stem cellsbreakdown → | 337 |
| 3 | 18 | |
| 4 | 25 | |
| 5 | 37 | |
| 6 | 46 | |
| 7 | 7 | |
| 8 | 24 | |
| 9 | 50 | |
| 10 | 115 | |
| 11 | 100 | |
| 12 | 52 | |
| 13 | 49 | |
| 14 | 82 | |
| 15 | 14 | |
| 16 | 39 | |
| 17 | 11 | |
| 18 | 32 | |
| 19 | 1 | |
| 20 | 125 |
About Erik Serrao
Erik Serrao is a scholar working on Virology, Infectious Diseases and Molecular Biology, having authored 30 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (26 papers), HIV/AIDS drug development and treatment (17 papers) and CRISPR and Genetic Engineering (8 papers). The work is most often cited by research in Virology (906 citations), Infectious Diseases (674 citations) and Molecular Biology (995 citations). Erik Serrao has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Alan Engelman, Nouri Neamati, Peter Cherepanov, Weifeng Wang, Srinivas Odde, Kavya Ramkumar, Gregory A. Sowd, Hao Wang, Eric M. Poeschla and Hind J. Fadel. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.